-+ 0.00%
-+ 0.00%
-+ 0.00%

Enanta Pharmaceuticals CEO Jay Luly Announces Retirement by February 1, 2027

PUBT·10/28/2026 11:07:19
Enanta Pharmaceuticals CEO Jay Luly Announces Retirement by February 1, 2027
  • Enanta Pharmaceuticals President and CEO Jay R. Luly, 70, will retire by February 1, 2027, following 23 years of leadership.
  • Luly will serve as a strategic advisor for the remainder of 2027 to support the transition.
  • The board has launched a search for his successor, considering internal and external candidates.
  • Tara L. Kieffer, most recently chief product strategy officer, was appointed to the newly created chief operating officer role.
  • Kieffer joined Enanta in 2020 following a 16-year career at Vertex Pharmaceuticals spanning research, clinical development and business functions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enanta Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261028569198) on October 28, 2026, and is solely responsible for the information contained therein.